Quick Takeaways: Why It Matters? M2 Ingredients is plugging its clinically studied, full‑spectrum mushroom portfolio into Anchor’s pet‑food customer base, effectively turning mushrooms into a ready‑to‑spec functional building block for gut, immune, and overall wellness claims i...
Quick Takeaways: Why It Matters? IFF is using PureStrong to push a dog-first probiotic paradigm—built on a single, canine-derived Limosilactobacillus reuteri strain, into a fast-growing, 3.2 billion dollar US pet supplement market that is stil...
Quick Takeaways: Why It Matters? Dyne Soft Chews extends PetAg’s brand from specialty nutrition into the fast‑growing daily supplement segment, using vet‑formulated, clinically studied ingredients to compete more directly with premium wellness chew players ...
Quick Takeaways: Why It Matters? The renewed partnership reinforces Royal Canin’s positioning as a science-first leader in obesity and weight-management diets, backed by real-world clinical outcomes from an academic center. By combining low-cost clinical care with precisio...
Quick Takeaways: Why It Matters? The deal adds another science‑forward brand to epiq’s portfolio and deepens its role as a specialty distributor that can take microbiome‑based innovations from H&H/Zesty Paws into the vet channel with supply-chain and market‑access...
Quick Takeaways: Why It Matters? A-DHA-PT gives veterinary neurologists a standardized, high‑dose DHA option developed under academic supervision, potentially making nutritional add‑on therapy a more routine consideration in dogs with idiopathic epilepsy where pharmacologic con...
